Treatment of acute migraine in the pediatric population

Current Treatment Options in Neurology

Volumn 12, Issue 3, 2010, Pages 178-185

  O'Brien, Hope L ^a   Kabbouche, Marielle A ^a   Hershey, Andrew D ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALMOTRIPTAN; DIHYDROERGOTAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; IBUPROFEN; KETOROLAC; METOCLOPRAMIDE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROCHLORPERAZINE; RIZATRIPTAN; SUMATRIPTAN; TRIPTAN DERIVATIVE; VALPROIC ACID; ZOLMITRIPTAN;

DISEASE SEVERITY; HUMAN; HYDRATION; INTRACTABLE PAIN; LIFESTYLE MODIFICATION; MIGRAINE; NAUSEA AND VOMITING; PEDIATRICS; REVIEW; SLEEP;

EID: 77953538856     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-010-0069-6     Document Type: Review

References (30)

1. Rassmussen BK, Jensen R, Schroll M, et al.: Epidemiology of headache in a general population-a prevalence study. J Clin Epidemiol 1991, 44:1147-1157.
2. Brousseau DC, Duffy SJ, Anderson AC, Linakis JG: Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac. Ann Emerg Med 2004, 43:256-262.
3. Siberstein SD: Practice parameter: evidence-based guidelines for migraine headache (an evidencebased review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000, 55:754-762.
4. Lewis DW, Ashwal S, Hershey A, et al.: Practice parameter: pharmacological treatment of migraine headache in children and adolescents. Neurology 2004, 63:2215-2224.
5. Eidlitz-Markus T, Haimi-Cohen Y, Steier D, Zeharia A: Effectiveness of nonpharmacologic treatment for migraine in young children. Headache 2009 Oct 5 (Epub ahead of print).
6. Hamalainen ML, Hoppu K, Valkeila E, Santvuori P: Ibuprofen or acetaminophen for the acute treatment of migraine in children. Neurology 1997, 48:103-107.
7. Lewis DW, Kellsein D, Sahl G, et al.: Children's ibuprofen suspension for the acute treatment of pediatric migraine. Headache 2002, 42(8):780-786.
8. Lipton RB, Golstein J, Baggish JS, et al.: Aspirin is efficacious for the treatment of acute migraine. Headache 2005, 45:283-292.
9. Matchar DB, Young WB, Rosenberg JH, et al.: Evidence- based guidelines for migraine headache in the primary care setting: pharmacological management of acute attacks. Neurology 2000, 54. http://www.aan.com/professionals/practice/ pdfs/ gl0087.pdf. Accessed October 31, 2009.
10. Larkin G: Intravenous ketorolac vs. intravenous prochlorperazine for the treatment of migraine headache. Acad Emerg Med 1999, 6:668-670.
11. Ahya SN, Flood K, Paranjothi S (Eds): The Washington Manual of Medical Therapeutics, edn 3. Philadelphia: Lippincott; 2001.
12. Schilling A, Corey R, Leonard M, Eghtesad B: Acetaminophen: old drug, new warnings. Cleve Clin J Med 2010, 77(1):19-27.
13. Winner P: Triptans for migraine management in adolescents. Headache 2002, 42:675-679.
14. AXERT (almotriptan malate): full prescribing information. Recent major changes. Available at http:// www.accessdata.fda.gov/drugsatfda-docs/label/2009/ 021001s010s011lbl.pdf. Accessed February 26, 2010.
15. Linder SL, Mathew NT, Cady RK, et al.: Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial. Headache 2008, 48:1326-1336. Almotriptan is the first triptan with US FDA approval for pediatric migraine.
16. Winner P, Lewis D, Visser H, et al.: Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study. Headache 2002, 42:49-55.
17. Winner P, Rothner AD, Saper J, et al.: A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics 2000, 106:989-997.
18. Rothner AD, Winner P, Nett R, et al.: Long-term tolerability of sumatriptan nasal spray for adolescent migraine: results of an open-label study. Clin Therapeut 2001, 22:1533-1546.
19. Lewis DW, Winner P, Hershey AD, Wasiewski WW: Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics 2007, 120:390-396.
20. Brandes JL, Kudrow D, Stark SR, et al.: Sumatriptannaproxen for acute treatment of migraine: a randomized trial. JAMA 2007, 297:1443-1454.
21. Linder SL: Treatment of childhood headache with dihydroergotamine mesylate. Headache 1994, 34:578-580.
22. Richer L: Graham, Klassen T, Rowe B: Emergency department management of acute migraine in children in Canada: a practice variation study. Headache 2007, 47(5):703-710.
23. Coppola M, Yearly DM, Leibold RA: Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med 1995, 26(5):541-546.
24. Peroutka SJ: Dopamine and migraine. Neurology 1997, 49:650-656.
25. Kabbouche MA, Vockell AL, LeCates SL, et al.: Tolerability and effectiveness of prochlorperazine for intractable migraine in children. Pediatrics 2001, 107(4):E62.
26. Rothner MA, Powers SW, Hershey AD, et al.: Inpatient treatment of status migraine with dihydroergotamine in children and adolescents. Headache 2009, 49:106-109.
27. Linder SL: Treatment of acute childhood migraine headache with dihydroergotamine mesylate. Headache 1994, 34:578-580.
28. Yonker ME: How do I do it reference for acute migraine treatment in children. Available at https:// www.americanheadachesociety.org/assets/How-I-Do- It-Reference-for-Acute-Migraine-Treatment-in-Children.pdf. Accessed November 1, 2009.
29. Schwartz TH, Karpitskiy VV, Sohn RS: Intravenous valproate sodium in the treatment of daily headache. Headache 2002, 42(6):519-522.
30. Hershey AD, Powers SW, Winner P, Kabbouche MA: Pediatric Headaches in Clinical Practice. Hoboken, NJ: Wiley-Blackwell; 2009. This book includes the most recent comprehensive review of diagnosis and treatment of pediatric migraine.